Use of inotropes and vasopressor agents in critically ill patients

British Journal of Pharmacology

Volumn 165, Issue 7, 2012, Pages 2015-2033

  Bangash, Mansoor N ^a   Kong, Ming Li ^a   Pearse, Rupert M ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

critical illness; haemodynamic shock; inotrope; vasopressor

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR; AMINOPHYLLINE; AMRINONE; BETA ADRENERGIC RECEPTOR; CALCIUM ION; DOBUTAMINE; DOPAMINE; DOPAMINE RECEPTOR; DOPEXAMINE; ENOXIMONE; EPHEDRINE; FENOLDOPAM; HYPERTENSIVE AGENT; INOTROPIC AGENT; LEVOSIMENDAN; METARAMINOL; MILRINONE; NORADRENALIN; PHENYLEPHRINE; PHOSPHODIESTERASE INHIBITOR; PLACEBO; TERLIPRESSIN; VASOPRESSIN;

ACUTE KIDNEY FAILURE; AMINO ACID SUBSTITUTION; APOPTOSIS; ASTHMA; AUTOOXIDATION; BACTERIAL GROWTH; BLOOD FLOW; BLOOD VESSEL TONE; CARDIOGENIC SHOCK; CLINICAL PHARMACOLOGY; CORONARY ARTERY BLOOD FLOW; CORONARY VASCULAR RESISTANCE; CRITICALLY ILL PATIENT; DRUG ACTIVITY; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG INDICATION; DRUG MEGADOSE; DRUG METABOLISM; DRUG RECEPTOR BINDING; EXOCYTOSIS; GASTROINTESTINAL TRACT; HEART AFTERLOAD; HEART ARREST; HEART ARRHYTHMIA; HEART EXCITATION; HEART FAILURE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE POTENTIAL; HEART OUTPUT; HEART PRELOAD; HEART RATE; HEART REPOLARIZATION; HEART VENTRICLE CONTRACTION; HUMAN; HYPOTENSION; IMMUNE SYSTEM; INTRACELLULAR SIGNALING; KIDNEY FUNCTION; LOADING DRUG DOSE; LOW DRUG DOSE; MEAN ARTERIAL PRESSURE; METABOLIC ACTIVATION; MICROVASCULATURE; PERFUSION PRESSURE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SEPTIC SHOCK; SIDE EFFECT; STRUCTURE ACTIVITY RELATION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; TISSUE PERFUSION; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION; VENOUS RETURN;

ACUTE KIDNEY INJURY; ANIMALS; CARDIAC OUTPUT; CARDIOTONIC AGENTS; CATECHOLAMINES; CRITICAL CARE; CRITICAL ILLNESS; HEART ARREST; HORMONES; HUMANS; MODELS, CARDIOVASCULAR; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; SEPSIS; VASOCONSTRICTOR AGENTS;

EID: 84858235634     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01588.x     Document Type: Review

References (246)

1. Abraham E, Kaneko DJ, Shenkar R, (1999). Effects of endogenous and exogenous catecholamines on LPS-induced neutrophil trafficking and activation. Am J Physiol 276: L1-L8. (Pubitemid 29061658)
2. Adamson RH, Liu B, Fry GN, Rubin LL, Curry FE, (1998). Microvascular permeability and number of tight junctions are modulated by cAMP. Am J Physiol 274: H1885-H1894.
3. Albanese J, Leone M, Garnier F, Bourgoin A, Antonini F, Martin C, (2004). Renal effects of norepinephrine in septic and nonseptic patients. Chest 126: 534-539. (Pubitemid 39093440)
4. Albert M, Losser MR, Hayon D, Faivre V, Payen D, (2004). Systemic and renal macro- and microcirculatory responses to arginine vasopressin in endotoxic rabbits. Crit Care Med 32: 1891-1898. (Pubitemid 39202366)
5. Alexander SPH, Mathie A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th Edition. Br J Pharmacol 164 (Suppl. 1): S1-S324.
6. Alia I, Esteban A, Gordo F, Lorente JA, Diaz C, Rodriguez JA, et al,. (1999). A randomized and controlled trial of the effect of treatment aimed at maximizing oxygen delivery in patients with severe sepsis or septic shock. Chest 115: 453-461. (Pubitemid 29083056)
7. Alousi AA, Johnson DC, (1986). Pharmacology of the bipyridines: amrinone and milrinone. Circulation 73: III10-III24.
8. Altenburg SP, Martins MA, Silva AR, Cordeiro RS, Castro-Faria-Neto HC, (1997). LPS-induced blood neutrophilia is inhibited by alpha 1-adrenoceptor antagonists: a role for catecholamines. J Leukoc Biol 61: 689-694. (Pubitemid 27276060)
9. Annane D, Vignon P, Renault A, Bollaert PE, Charpentier C, Martin C, et al,. (2007). Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet 370: 676-684. (Pubitemid 47299251)
10. Arcaroli J, Yang KY, Yum HK, Kupfner J, Pitts TM, Park JS, et al,. (2002). Effects of catecholamines on kinase activation in lung neutrophils after hemorrhage or endotoxemia. J Leukoc Biol 72: 571-579.
11. Aviado DM Jr, Schmidt CF, (1957). Effects of sympathomimetic drugs on pulmonary circulation: with special reference to a new pulmonary vasodilator. J Pharmacol Exp Ther 120: 512-527.
12. Azoui R, Cuche JL, Renaud JF, Safar M, Dagher G, (1996). A dopamine transporter in human erythrocytes: modulation by insulin. Exp Physiol 81: 421-434. (Pubitemid 26163078)
13. Bailey AR, Burchett KR, (1997). Effect of low-dose dopamine on serum concentrations of prolactin in critically ill patients. Br J Anaesth 78: 97-99. (Pubitemid 27047424)
14. Ballou LM, Tian PY, Lin HY, Jiang YP, Lin RZ, (2001). Dual regulation of glycogen synthase kinase-3beta by the alpha1A-adrenergic receptor. J Biol Chem 276: 40910-40916.
15. Barrett LK, Singer M, Clapp LH, (2007). Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med 35: 33-40. (Pubitemid 46035674)
16. Barth E, Albuszies G, Baumgart K, Matejovic M, Wachter U, Vogt J, et al,. (2007). Glucose metabolism and catecholamines. Crit Care Med 35: S508-S518. (Pubitemid 47312187)
17. Bass AS, Kohli JD, Lubbers N, Goldberg LI, (1987). Mechanisms mediating the positive inotropic and chronotropic changes induced by dopexamine in the anesthetized dog. J Pharmacol Exp Ther 242: 940-944. (Pubitemid 17156535)
18. Beale RJ, Hollenberg SM, Vincent JL, Parrillo JE, (2004). Vasopressor and inotropic support in septic shock: an evidence-based review. Crit Care Med 32: S455-S465. (Pubitemid 39489021)
19. Beani L, Bianchi C, Crema A, (1969). The effect of catecholamines and sympathetic stimulation on the release of acetylcholine from the guinea-pig colon. Br J Pharmacol 36: 1-17.
20. Bearn AG, Billing B, Sherlock S, (1951). The effect of adrenaline and noradrenaline on hepatic blood flow and splanchnic carbohydrate metabolism in man. J Physiol 115: 430-441.
21. Beck G, Brinkkoetter P, Hanusch C, Schulte J, Van Ackern K, Van Der Woude FJ, et al,. (2004). Clinical review: immunomodulatory effects of dopamine in general inflammation. Crit Care 8: 485-491. (Pubitemid 40073684)
22. Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J, (2000). Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 356: 2139-2143.
23. Bender JS, Smith-Meek MA, Jones CE, (1997). Routine pulmonary artery catheterization does not reduce morbidity and mortality of elective vascular surgery: results of a prospective, randomized trial. Ann Surg 226: 229-236.
24. Bergmann M, Gornikiewicz A, Sautner T, Waldmann E, Weber T, Mittlbock M, et al,. (1999). Attenuation of catecholamine-induced immunosuppression in whole blood from patients with sepsis. Shock 12: 421-427.
25. Bergquist J, Tarkowski A, Ekman R, Ewing A, (1994). Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop. Proc Natl Acad Sci USA 91: 12912-12916.
26. Berlauk JF, Abrams JH, Gilmour IJ, O'Connor SR, Knighton DR, Cerra FB, (1991). Preoperative optimization of cardiovascular hemodynamics improves outcome in peripheral vascular surgery. A prospective, randomized clinical trial. Ann Surg 214: 289-297. discussion 298-9.
27. Berman SB, Hastings TG, (1999). Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease. J Neurochem 73: 1127-1137. (Pubitemid 29395471)
28. Bernadich C, Bandi JC, Melin P, Bosch J, (1998). Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension. Hepatology 27: 351-356. (Pubitemid 28081046)
29. Bernardin G, Strosberg AD, Bernard A, Mattei M, Marullo S, (1998). Beta-adrenergic receptor-dependent and -independent stimulation of adenylate cyclase is impaired during severe sepsis in humans. Intensive Care Med 24: 1315-1322. (Pubitemid 28564456)
30. Bertorello A, Aperia A, (1990). Inhibition of proximal tubule Na(+)-K(+)-ATPase activity requires simultaneous activation of DA1 and DA2 receptors. Am J Physiol 259: F924-F928.
31. Bindoli A, Rigobello MP, Deeble DJ, (1992). Biochemical and toxicological properties of the oxidation products of catecholamines. Free Radic Biol Med 13: 391-405.
32. Bohm M, Kirchmayr R, Gierschik P, Erdmann E, (1995). Increase of myocardial inhibitory G-proteins in catecholamine-refractory septic shock or in septic multiorgan failure. Am J Med 98: 183-186.
33. Bohm M, Deutsch HJ, Hartmann D, Rosee KL, Stablein A, (1997). Improvement of postreceptor events by metoprolol treatment in patients with chronic heart failure. J Am Coll Cardiol 30: 992-996. (Pubitemid 27435892)
34. Bonazzi M, Gentile F, Biasi GM, Migliavacca S, Esposti D, Cipolla M, et al,. (2002). Impact of perioperative haemodynamic monitoring on cardiac morbidity after major vascular surgery in low risk patients. A randomised pilot trial. Eur J Vasc Endovasc Surg 23: 445-451. (Pubitemid 41079428)
35. Boss O, Hagen T, Lowell BB, (2000). Uncoupling proteins 2 and 3: potential regulators of mitochondrial energy metabolism. Diabetes 49: 143-156. (Pubitemid 30070991)
36. Bove T, Landoni G, Calabro MG, Aletti G, Marino G, Cerchierini E, et al,. (2005). Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial. Circulation 111: 3230-3235. (Pubitemid 40874994)
37. Boxer LA, Allen JM, Baehner RL, (1980). Diminished polymorphonuclear leukocyte adherence. Function dependent on release of cyclic AMP by endothelial cells after stimulation of beta-receptors by epinephrine. J Clin Invest 66: 268-274. (Pubitemid 10092624)
38. Boyd O, Grounds RM, Bennett ED, (1993). A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. JAMA 270: 2699-2707. (Pubitemid 23350967)
39. Braun JP, Jasulaitis D, Moshirzadeh M, Doepfmer UR, Kastrup M, von Heymann C, et al,. (2006). Levosimendan may improve survival in patients requiring mechanical assist devices for post-cardiotomy heart failure. Crit Care 10: R17.
40. Brodde OE, Michel MC, (1999). Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev 51: 651-690.
41. Brown RA, Dixon J, Farmer JB, Hall JC, Humphries RG, Ince F, et al,. (1985). Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors. Br J Pharmacol 85: 599-608. (Pubitemid 15028800)
42. Burniston JG, Ellison GM, Clark WA, Goldspink DF, Tan LB, (2005). Relative toxicity of cardiotonic agents: some induce more cardiac and skeletal myocyte apoptosis and necrosis in vivo than others. Cardiovasc Toxicol 5: 355-364. (Pubitemid 43021258)
43. Callaham M, Madsen CD, Barton CW, Saunders CE, Pointer J, (1992). A randomized clinical trial of high-dose epinephrine and norepinephrine vs standard-dose epinephrine in prehospital cardiac arrest. JAMA 268: 2667-2672.
44. Callaway CW, Hostler D, Doshi AA, Pinchalk M, Roth RN, Lubin J, et al,. (2006). Usefulness of vasopressin administered with epinephrine during out-of-hospital cardiac arrest. Am J Cardiol 98: 1316-1321. (Pubitemid 44666635)
45. Carlson SL, Beiting DJ, Kiani CA, Abell KM, McGillis JP, (1996). Catecholamines decrease lymphocyte adhesion to cytokine-activated endothelial cells. Brain Behav Immun 10: 55-67. (Pubitemid 26168470)
46. Chiu T, Reid IA, (1996). Role of cyclic GMP-inhibitable phosphodiesterase and nitric oxide in the beta adrenoceptor control of renin secretion. J Pharmacol Exp Ther 278: 793-799. (Pubitemid 27167048)
47. Chiu YJ, Hu SH, Reid IA, (1999). Inhibition of phosphodiesterase III with milrinone increases renin secretion in human subjects. J Pharmacol Exp Ther 290: 16-19. (Pubitemid 29302298)
48. Choi WI, Kwon KY, Seo JW, Beagle J, Quinn DA, Hales CA, (2009). The role of phosphodiesterase 3 in endotoxin-induced acute kidney injury. BMC Infect Dis 9: 80.
49. Chopra M, Sharma AC, (2009). Contractile response of norepinephrine is modulated by caspase-3 in adult rat ventricular myocytes isolated from septic rat heart. Pharmacol Res 60: 303-313.
50. Clutter WE, Bier DM, Shah SD, Cryer PE, (1980). Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. J Clin Invest 66: 94-101. (Pubitemid 10071353)
51. Cohn JN, (1965). Comparative cardiovascular effects of tyramine, ephedrine, and norepinephrine in man. Circ Res 16: 174-182.
52. Colucci WS, (1991). Cardiovascular effects of milrinone. Am Heart J 121: 1945-1947.
53. Costa VM, Silva R, Ferreira R, Amado F, Carvalho F, de Lourdes Bastos M, et al,. (2009). Adrenaline in pro-oxidant conditions elicits intracellular survival pathways in isolated rat cardiomyocytes. Toxicology 257: 70-79.
54. Coulanges V, Andre P, Ziegler O, Buchheit L, Vidon DJ, (1997). Utilization of iron-catecholamine complexes involving ferric reductase activity in Listeria monocytogenes. Infect Immun 65: 2778-2785. (Pubitemid 27264108)
55. Crile G, Dolley DH, (1906). An experimental research into the resuscitation of dogs killed by anesthetics and asphyxia. J Exp Med 8: 713-725.
56. Dart R, (2004). Medical Toxicology. Lippincott Williams & Wilkins: Philadelphia, PA.
57. Dawson JR, Thompson DS, Signy M, Juul SM, Turnbull P, Jenkins BS, et al,. (1985). Acute haemodynamic and metabolic effects of dopexamine, a new dopaminergic receptor agonist, in patients with chronic heart failure. Br Heart J 54: 313-320. (Pubitemid 15236462)
58. Day NP, Phu NH, Bethell DP, Mai NT, Chau TT, Hien TT, et al,. (1996). The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection. Lancet 348: 219-223. (Pubitemid 26254195)
59. De Backer D, Creteur J, Silva E, Vincent JL, (2003). Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med 31: 1659-1667. (Pubitemid 36714218)
60. De Backer D, Creteur J, Dubois MJ, Sakr Y, Vincent JL, (2004). Microvascular alterations in patients with acute severe heart failure and cardiogenic shock. Am Heart J 147: 91-99. (Pubitemid 38037403)
61. De Backer D, Creteur J, Dubois MJ, Sakr Y, Koch M, Verdant C, et al,. (2006). The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med 34: 403-408. (Pubitemid 43145619)
62. De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al,. (2010). Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 362: 779-789.
63. De Ponti F, Giaroni C, Cosentino M, Lecchini S, Frigo G, (1996). Adrenergic mechanisms in the control of gastrointestinal motility: from basic science to clinical applications. Pharmacol Ther 69: 59-78.
64. Dellinger RP, (2003). Cardiovascular management of septic shock. Crit Care Med 31: 946-955. (Pubitemid 36379609)
65. Dimitrov S, Lange T, Born J, (2010). Selective mobilization of cytotoxic leukocytes by epinephrine. J Immunol 184: 503-511.
66. Dive A, Foret F, Jamart J, Bulpa P, Installe E, (2000). Effect of dopamine on gastrointestinal motility during critical illness. Intensive Care Med 26: 901-907. (Pubitemid 30616043)
67. Eisenhofer G, (2001). The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. Pharmacol Ther 91: 35-62. (Pubitemid 33055773)
68. El-Bahr SM, Kahlbacher H, Patzl M, Palme RG, (2006). Binding and clearance of radioactive adrenaline and noradrenaline in sheep blood. Vet Res Commun 30: 423-432.
69. Ensinger H, Weichel T, Lindner KH, Grunert A, Ahnefeld FW, (1993). Effects of norepinephrine, epinephrine, and dopamine infusions on oxygen consumption in volunteers. Crit Care Med 21: 1502-1508. (Pubitemid 23312484)
70. Ensinger H, Weichel T, Lindner KH, Grunert A, Georgieff M, (1995). Are the effects of noradrenaline, adrenaline and dopamine infusions on VO2 and metabolism transient? Intensive Care Med 21: 50-56.
71. Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G, (1990). Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev 70: 963-985. (Pubitemid 20364820)
72. Foster RW, (1966). The pharmacology of pressor drugs. Br J Anaesth 38: 690-704.
73. Fruhwald S, Scheidl S, Toller W, Petnehazy T, Holzer P, Metzler H, et al,. (2000). Low potential of dobutamine and dopexamine to block intestinal peristalsis as compared with other catecholamines. Crit Care Med 28: 2893-2897.
74. Furness JB, Marshall JM, (1974). Correlation of the directly observed responses of mesenteric vessles of the rat to nerve stimulation and noradrenaline with the distribution of adrenergic nerves. J Physiol 239: 75-88.
75. Galster AD, Clutter WE, Cryer PE, Collins JA, Bier DM, (1981). Epinephrine plasma thresholds for lipolytic effects in man: measurements of fatty acid transport with [l-13C]palmitic acid. J Clin Invest 67: 1729-1738. (Pubitemid 11127565)
76. Ganong WF, (2003). Review of Medical Physiology. Lange Medical Books/McGraw Hill: London.
77. Garcia-Cazarin ML, Smith JL, Clair DK, Piascik MT, (2008). The alpha1D-adrenergic receptor induces vascular smooth muscle apoptosis via a p53-dependent mechanism. Mol Pharmacol 74: 1000-1007.
78. Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A, et al,. (1995). A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med 333: 1025-1032.
79. Goldberg LI, Rajfer SI, (1985). Dopamine receptors: applications in clinical cardiology. Circulation 72: 245-248. (Pubitemid 15019870)
80. Gordon AC, Russell JA, Walley KR, Singer J, Ayers D, Storms MM, et al,. (2010). The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Med 36: 83-91.
81. Gosain A, Muthu K, Gamelli RL, DiPietro LA, (2007). Norepinephrine suppresses wound macrophage phagocytic efficiency through alpha- and beta-adrenoreceptor dependent pathways. Surgery 142: 170-179. (Pubitemid 47198679)
82. Graefe K, Bonisch H, (1988). The transport of amines across the axonal membranes of noradrenergic and dopaminergic neurones. In:, Trendelenburg U, (ed.). Catecholamines. Springer-Verlag: Berlin, pp. 193-245.
83. Greeley W, Steven J, Nicolson S, Kern F, (2000). Anesthesia for pediatric cardiac surgery. In:, Miller R, (ed.). Anesthesia. Churchill Livingstone: New York, pp. 1805-1847.
84. Guerin JP, Levraut J, Samat-Long C, Leverve X, Grimaud D, Ichai C, (2005). Effects of dopamine and norepinephrine on systemic and hepatosplanchnic hemodynamics, oxygen exchange, and energy balance in vasoplegic septic patients. Shock 23: 18-24. (Pubitemid 40083022)
85. Gueugniaud PY, Mols P, Goldstein P, Pham E, Dubien PY, Deweerdt C, et al,. (1998). A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. European Epinephrine Study Group. N Engl J Med 339: 1595-1601. (Pubitemid 28536134)
86. Gueugniaud PY, David JS, Chanzy E, Hubert H, Dubien PY, Mauriaucourt P, et al,. (2008). Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. N Engl J Med 359: 21-30. (Pubitemid 351931093)
87. Guimaraes S, Moura D, (2001). Vascular adrenoceptors: an update. Pharmacol Rev 53: 319-356. (Pubitemid 32476119)
88. Halpenny M, Rushe C, Breen P, Cunningham AJ, Boucher-Hayes D, Shorten GD, (2002). The effects of fenoldopam on renal function in patients undergoing elective aortic surgery. Eur J Anaesthesiol 19: 32-39. (Pubitemid 34982553)
89. Hao L, Nishimura T, Wo H, Fernandez-Patron C, (2006). Vascular responses to alpha1-adrenergic receptors in small rat mesenteric arteries depend on mitochondrial reactive oxygen species. Arterioscler Thromb Vasc Biol 26: 819-825. (Pubitemid 43732157)
90. Harvey S, Stevens K, Harrison D, Young D, Brampton W, McCabe C, et al,. (2006). An evaluation of the clinical and cost-effectiveness of pulmonary artery catheters in patient management in intensive care: a systematic review and a randomised controlled trial. Health Technol Assess 10: iii-iv, ix-xi, 1-133.
91. Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds CJ, Watson D, (1994). Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 330: 1717-1722. (Pubitemid 24171030)
92. Hazinski MF, Nolan JP, Billi JE, Bottiger BW, Bossaert L, de Caen AR, et al,. (2010). Part 1: executive summary: 2010 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Circulation 122: S250-S275.
93. Heck DA, Bylund DB, (1997). Mechanism of down-regulation of alpha-2 adrenergic receptor subtypes. J Pharmacol Exp Ther 282: 1219-1227. (Pubitemid 27408298)
94. Hendriks-Balk MC, Peters SL, Michel MC, Alewijnse AE, (2008). Regulation of G protein-coupled receptor signalling: focus on the cardiovascular system and regulator of G protein signalling proteins. Eur J Pharmacol 585: 278-291.
95. Hendriks-Balk MC, Tjon-Atsoi M, Hajji N, Alewijnse AE, Peters SL, (2009). LPS differentially affects vasoconstrictor responses: a potential role for RGS16? J Physiol Biochem 65: 71-83.
96. Henkel JG, Sikand N, Makriyannis A, Gianutsos G, (1981). Synthesis and adrenoceptor affinity of some highly polar beta-substituted catecholamines. J Med Chem 24: 1258-1260. (Pubitemid 12208787)
97. Hoffbrand BI, Forsyth RP, (1973). Regional blood flow changes during norepinephrine, tyramine and methoxamine infusions in the unanesthetized rhesus monkey. J Pharmacol Exp Ther 184: 656-661.
98. Hofstetter C, Boost KA, Hoegl S, Flondor M, Scheller B, Muhl H, et al,. (2007). Norepinephrine and vasopressin counteract anti-inflammatory effects of isoflurane in endotoxemic rats. Int J Mol Med 20: 597-604.
99. Horn NA, Anastase DM, Hecker KE, Baumert JH, Robitzsch T, Rossaint R, (2005). Epinephrine enhances platelet-neutrophil adhesion in whole blood in vitro. Anesth Analg 100: 520-526. (Pubitemid 40170553)
100. Hughes DT, Sperandio V, (2008). Inter-kingdom signalling: communication between bacteria and their hosts. Nat Rev Microbiol 6: 111-120.
101. von Hundelshausen P, Koenen RR, Weber C, (2009). Platelet-mediated enhancement of leukocyte adhesion. Microcirculation 16: 84-96.
102. Ikarugi H, Shibata M, Shibata S, Ishii H, Taka T, Yamamoto J, (2003). High intensity exercise enhances platelet reactivity to shear stress and coagulation during and after exercise. Pathophysiol Haemost Thromb 33: 127-133. (Pubitemid 38698113)
103. Ince C, (2005). The microcirculation is the motor of sepsis. Crit Care 9 (Suppl. 4): S13-S19. (Pubitemid 41498527)
104. Jakob SM, Ruokonen E, Takala J, (2002). Effects of dopamine on systemic and regional blood flow and metabolism in septic and cardiac surgery patients. Shock 18: 8-13.
105. Jhanji S, Lee C, Watson D, Hinds C, Pearse RM, (2009a). Microvascular flow and tissue oxygenation after major abdominal surgery: association with post-operative complications. Intensive Care Med 35: 671-677.
106. Jhanji S, Stirling S, Patel N, Hinds CJ, Pearse RM, (2009b). The effect of increasing doses of norepinephrine on tissue oxygenation and microvascular flow in patients with septic shock. Crit Care Med 37: 1961-1966.
107. Jhanji S, Vivian-Smith A, Lucena-Amaro S, Watson D, Hinds CJ, Pearse RM, (2010). Haemodynamic optimisation improves tissue microvascular flow and oxygenation after major surgery: a randomised controlled trial. Crit Care 14: R151.
108. Jiang JL, Peng YP, Qiu YH, Wang JJ, (2009). Adrenoreceptor-coupled signal-transduction mechanisms mediating lymphocyte apoptosis induced by endogenous catecholamines. J Neuroimmunol 213: 100-111.
109. Kadoi Y, Saito S, Kawahara F, Nishihara F, Goto F, (2002). G-protein coupled receptor kinase 2 is altered during septic shock in rats. J Surg Res 108: 69-76. (Pubitemid 35373817)
110. Kellum JA, Decker JM, (2001). Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 29: 1526-1531. (Pubitemid 32762331)
111. Kobayashi S, Endou M, Sakuraya F, Matsuda N, Zhang XH, Azuma M, et al,. (2003). The sympathomimetic actions of l-ephedrine and d-pseudoephedrine: direct receptor activation or norepinephrine release? Anesth Analg 97: 1239-1245. (Pubitemid 37310111)
112. Kopin IJ, (1985). Catecholamine metabolism: basic aspects and clinical significance. Pharmacol Rev 37: 333-364. (Pubitemid 16106624)
113. Kosterlitz HW, Lydon RJ, Watt AJ, (1970). The effects of adrenaline, noradrenaline and isoprenaline on inhibitory alpha- and beta-adrenoceptors in the longitudinal muscle of the guinea-pig ileum. Br J Pharmacol 39: 398-413.
114. Landoni G, Biondi-Zoccai GG, Tumlin JA, Bove T, De Luca M, Calabro MG, et al,. (2007). Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. Am J Kidney Dis 49: 56-68. (Pubitemid 44932198)
115. Landoni G, Biondi-Zoccai GG, Marino G, Bove T, Fochi O, Maj G, et al,. (2008). Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis. J Cardiothorac Vasc Anesth 22: 27-33. (Pubitemid 351179395)
116. Lange M, Morelli A, Ertmer C, Koehler G, Broking K, Hucklenbruch C, et al,. (2007). Continuous versus bolus infusion of terlipressin in ovine endotoxemia. Shock 28: 623-629. (Pubitemid 350287450)
117. Lehtonen LA, Antila S, Pentikainen PJ, (2004). Pharmacokinetics and pharmacodynamics of intravenous inotropic agents. Clin Pharmacokinet 43: 187-203. (Pubitemid 38293791)
118. Levick J, (2003). An Introduction to Cardiovascular Physiology. Hodder Arnold: London.
119. Levy B, Desebbe O, Montemont C, Gibot S, (2008). Increased aerobic glycolysis through beta2 stimulation is a common mechanism involved in lactate formation during shock states. Shock 30: 417-421.
120. Lewis SJ, Hoque A, Walton TM, Kooy NW, (2005). Potential role of nitration and oxidation reactions in the effects of peroxynitrite on the function of beta-adrenoceptor sub-types in the rat. Eur J Pharmacol 518: 187-194. (Pubitemid 41133644)
121. Lipowsky HH, (2005). Microvascular rheology and hemodynamics. Microcirculation 12: 5-15. (Pubitemid 40450614)
122. Lobo SM, Salgado PF, Castillo VG, Borim AA, Polachini CA, Palchetti JC, et al,. (2000). Effects of maximizing oxygen delivery on morbidity and mortality in high-risk surgical patients. Crit Care Med 28: 3396-3404.
123. Lokhandwala MF, Amenta F, (1991). Anatomical distribution and function of dopamine receptors in the kidney. FASEB J 5: 3023-3030. (Pubitemid 21892861)
124. Ludmer PL, Wright RF, Arnold JM, Ganz P, Braunwald E, Colucci WS, (1986). Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique. Circulation 73: 130-137. (Pubitemid 16132422)
125. Lullman H, Mohr K, Ziegler A, Bieger D, (2000). Color Atlas of Pharmacology. Thieme: Stuttgart.
126. Lunemann JD, Buttgereit F, Tripmacher R, Baerwald CG, Burmester GR, Krause A, (2001). Norepinephrine inhibits energy metabolism of human peripheral blood mononuclear cells via adrenergic receptors. Biosci Rep 21: 627-635. (Pubitemid 34816192)
127. Maayani S, Schwarz T, Craddock-Royal B, Tagliente TM, (2001). Activation of the alpha(2A)-adrenoceptor mediates deceleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro. Platelets 12: 359-375. (Pubitemid 32896893)
128. Macarthur H, Westfall TC, Riley DP, Misko TP, Salvemini D, (2000). Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc Natl Acad Sci USA 97: 9753-9758. (Pubitemid 30650848)
129. Majerus TC, Dasta JF, Bauman JL, Danziger LH, Ruffolo RR Jr, (1989). Dobutamine: ten years later. Pharmacotherapy 9: 245-259. (Pubitemid 19229533)
130. Marshall JM, (1982). The influence of the sympathetic nervous system on individual vessels of the microcirculation of skeletal muscle of the rat. J Physiol 332: 169-186. (Pubitemid 13253448)
131. Martikainen TJ, Tenhunen JJ, Uusaro A, Ruokonen E, (2003). The effects of vasopressin on systemic and splanchnic hemodynamics and metabolism in endotoxin shock. Anesth Analg 97: 1756-1763. (Pubitemid 37475134)
132. Martin SW, Broadley KJ, (1995). Renal vasodilatation by dopexamine and fenoldopam due to alpha 1-adrenoceptor blockade. Br J Pharmacol 115: 349-355.
133. Martin NP, Whalen EJ, Zamah MA, Pierce KL, Lefkowitz RJ, (2004). PKA-mediated phosphorylation of the beta1-adrenergic receptor promotes Gs/Gi switching. Cell Signal 16: 1397-1403. (Pubitemid 39277504)
134. Matthews SB, Henderson AH, Campbell AK, (1985). The adrenochrome pathway: the major route for adrenalin catabolism by polymorphonuclear leucocytes. J Mol Cell Cardiol 17: 339-348. (Pubitemid 15030723)
135. Mebazaa A, Nieminen MS, Packer M, Cohen-Solal A, Kleber FX, Pocock SJ, et al,. (2007). Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA 297: 1883-1891. (Pubitemid 46707842)
136. Mehran R, Nikolsky E, (2006). Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl 69: S11-S15.
137. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG, (1998). Dopamine receptors: from structure to function. Physiol Rev 78: 189-225. (Pubitemid 28070979)
138. Morelli A, Ricci Z, Bellomo R, Ronco C, Rocco M, Conti G, et al,. (2005). Prophylactic fenoldopam for renal protection in sepsis: a randomized, double-blind, placebo-controlled pilot trial. Crit Care Med 33: 2451-2456. (Pubitemid 41682094)
139. Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Laderchi A, et al,. (2008). Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial. Crit Care 12: R143.
140. Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Cecchini V, et al,. (2009). Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. Crit Care 13: R130.
141. Moretti A, Weig HJ, Ott T, Seyfarth M, Holthoff HP, Grewe D, et al,. (2002). Essential myosin light chain as a target for caspase-3 in failing myocardium. Proc Natl Acad Sci USA 99: 11860-11865. (Pubitemid 34994489)
142. Moss J, Renz C, (2000). The autonomic system. In:, Miller R, (ed.). Anesthesia. Churchill Livingstone: New York, pp. 523-577.
143. Motomura S, Brodde OE, Schumann HJ, (1978). No evidence for involvement of dopaminergic receptors in the positive inotropic action of dopamine on the isolated rabbit papillary muscle. Jpn J Pharmacol 28: 145-153. (Pubitemid 8329729)
144. Mousdale S, Clyburn PA, Mackie AM, Groves ND, Rosen M, (1988). Comparison of the effects of dopamine, dobutamine, and dopexamine upon renal blood flow: a study in normal healthy volunteers. Br J Clin Pharmacol 25: 555-560.
145. Mukherjee C, Caron MG, Mullikin D, Lefkowitz RJ, (1976). Structure-activity relationships of adenylate cyclase-coupled beta adrenergic receptors: determination by direct binding studies. Mol Pharmacol 12: 16-31.
146. Muller S, How OJ, Hermansen SE, Stenberg TA, Sager G, Myrmel T, (2008). Vasopressin impairs brain, heart and kidney perfusion: an experimental study in pigs after transient myocardial ischemia. Crit Care 12: R20.
147. Muthu K, Deng J, Gamelli R, Shankar R, Jones SB, (2005). Adrenergic modulation of cytokine release in bone marrow progenitor-derived macrophage following polymicrobial sepsis. J Neuroimmunol 158: 50-57. (Pubitemid 39626070)
148. Myburgh JA, Higgins A, Jovanovska A, Lipman J, Ramakrishnan N, Santamaria J, (2008). A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 34: 2226-2234.
149. Nakada TA, Russell JA, Boyd JH, Aguirre-Hernandez R, Thain KR, Thair SA, et al,. (2010). beta2-Adrenergic receptor gene polymorphism is associated with mortality in septic shock. Am J Respir Crit Care Med 181: 143-149.
150. Natalini G, Schivalocchi V, Rosano A, Taranto M, Pletti C, Bernardini A, (2005). Norepinephrine and metaraminol in septic shock: a comparison of the hemodynamic effects. Intensive Care Med 31: 634-637. (Pubitemid 40684979)
151. Navegantes LC, Resano NM, Migliorini RH, Kettelhut IC, (2001). Catecholamines inhibit Ca(2+)-dependent proteolysis in rat skeletal muscle through beta(2)-adrenoceptors and cAMP. Am J Physiol Endocrinol Metab 281: E449-E454.
152. Neri M, Cerretani D, Fiaschi AI, Laghi PF, Lazzerini PE, Maffione AB, et al,. (2007). Correlation between cardiac oxidative stress and myocardial pathology due to acute and chronic norepinephrine administration in rats. J Cell Mol Med 11: 156-170. (Pubitemid 46439634)
153. Nolan JP, Soar J, Zideman DA, Biarent D, Bossaert LL, Deakin C, et al,. (2010). European resuscitation council guidelines for resuscitation 2010: section 1. Executive summary. Resuscitation 81: 1219-1276.
154. Oberbeck R, (2006). Catecholamines: physiological immunomodulators during health and illness. Curr Med Chem 13: 1979-1989.
155. Olsen NV, Lund J, Jensen PF, Espersen K, Kanstrup IL, Plum I, et al,. (1993). Dopamine, dobutamine, and dopexamine. A comparison of renal effects in unanesthetized human volunteers.
156. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, et al,. (1991). Effect of oral milrinone on mortality in severe chronic heart
157. Panetta R, Guo Y, Magder S, Greenwood MT, (1999). Regulators of G-protein signaling (RGS) 1 and 16 are induced in response to bacterial lipopolysaccharide and stimulate c-fos promoter expression. Biochem Biophys Res Commun 259: 550-556. (Pubitemid 29335571)
158. Paradis NA, Martin GB, Rivers EP, Goetting MG, Appleton TJ, Feingold M, et al,. (1990). Coronary perfusion pressure and the return of spontaneous circulation in human cardiopulmonary resuscitation. JAMA 263: 1106-1113. (Pubitemid 20047444)
159. Patel RN, Arteaga RB, Mandawat MK, Thornton JW, Robinson VJ, (2007). Pharmacologic stress myocardial perfusion imaging. South Med J 100: 1006-1014. quiz 1004. (Pubitemid 47537885)
160. Patrick WD, Freedman J, McEwen T, Light RB, Ludwig L, Roberts D, (1995). A randomized, double-blind comparison of methoxamine and epinephrine in human cardiopulmonary arrest. Am J Respir Crit Care Med 152: 519-523.
161. Pearse RM, Dawson D, Fawcett J, Rhodes A, Grounds RM, Bennett ED, (2005). Early goal-directed therapy after major surgery reduces complications and duration of hospital stay. A randomised, controlled trial. Crit Care 9: R687-R693.
162. Pearse RM, Belsey JD, Cole JN, Bennett ED, (2008). Effect of dopexamine infusion on mortality following major surgery: individual patient data meta-regression analysis of published clinical trials. Crit Care Med 36: 1323-1329. (Pubitemid 351482684)
163. Pearson JW, Redding JS, (1963a). Epinephrine in Cardiac Resuscitation. Am Heart J 66: 210-214.
164. Pearson JW, Redding JS, (1963b). The role of epinephrine in cardiac resuscitation. Anesth Analg 42: 599-606.
165. Pero RS, Borchers MT, Spicher K, Ochkur SI, Sikora L, Rao SP, et al,. (2007). Galphai2-mediated signaling events in the endothelium are involved in controlling leukocyte extravasation. Proc Natl Acad Sci USA 104: 4371-4376. (Pubitemid 47186233)
166. Perondi MB, Reis AG, Paiva EF, Nadkarni VM, Berg RA, (2004). A comparison of high-dose and standard-dose epinephrine in children with cardiac arrest. N Engl J Med 350: 1722-1730. (Pubitemid 38501141)
167. Petersen JW, Felker GM, (2008). Inotropes in the management of acute heart failure. Crit Care Med 36: S106-S111.
168. Peterson G, Kumar A, Gart E, Narayanan S, (2011). Catecholamines increase conjugative gene transfer between enteric bacteria. Microb Pathog 51: 1-2.
169. Philipu A, Matthaei H, (1988). Transport and storage of catecholamines in vesicles. In:, Trendelenburg U, (ed.). Catecholamines. Springer-Verlag: Berlin, pp. 1-42.
170. Van Der Poll T, Levi M, Dentener M, Jansen PM, Coyle SM, Braxton CC, et al,. (1997). Epinephrine exerts anticoagulant effects during human endotoxemia. J Exp Med 185: 1143-1148. (Pubitemid 27136807)
171. Polonen P, Ruokonen E, Hippelainen M, Poyhonen M, Takala J, (2000). A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients. Anesth Analg 90: 1052-1059. (Pubitemid 30253449)
172. Porta F, Takala J, Weikert C, Kaufmann P, Krahenbuhl S, Jakob SM, (2006). Effect of endotoxin, dobutamine and dopamine on muscle mitochondrial respiration in vitro. J Endotoxin Res 12: 358-366. (Pubitemid 47487892)
173. Porta F, Bracht H, Weikert C, Beck M, Takala J, Brandt S, et al,. (2009). Effects of endotoxin and catecholamines on hepatic mitochondrial respiration. Inflammation 32: 315-321.
174. Prielipp RC, MacGregor DA, Butterworth JF, Meredith JW, Levy JH, Wood KE, et al,. (1996). Pharmacodynamics and pharmacokinetics of milrinone administration to increase oxygen delivery in critically ill patients. Chest 109: 1291-1301.
175. Qiu YH, Cheng C, Dai L, Peng YP, (2005). Effect of endogenous catecholamines in lymphocytes on lymphocyte function. J Neuroimmunol 167: 45-52. (Pubitemid 41242286)
176. Rashid AH, Brieva JL, Stokes B, (2009). Incidence of contrast-induced nephropathy in intensive care patients undergoing computerised tomography and prevalence of risk factors. Anaesth Intensive Care 37: 968-975.
177. Regueira T, Banziger B, Djafarzadeh S, Brandt S, Gorrasi J, Takala J, et al,. (2008). Norepinephrine to increase blood pressure in endotoxaemic pigs is associated with improved hepatic mitochondrial respiration. Crit Care 12: R88.
178. Rehberg S, Ertmer C, Vincent JL, Morelli A, Schneider M, Lange M, et al,. (2011). Role of selective V1a receptor agonism in ovine septic shock. Crit Care Med 39: 119-125.
179. Reinelt H, Radermacher P, Fischer G, Geisser W, Wachter U, Wiedeck H, et al,. (1997). Effects of a dobutamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock. Anesthesiology 86: 818-824. (Pubitemid 27174722)
180. Reinelt H, Radermacher P, Kiefer P, Fischer G, Wachter U, Vogt J, et al,. (1999). Impact of exogenous beta-adrenergic receptor stimulation on hepatosplanchnic oxygen kinetics and metabolic activity in septic shock. Crit Care Med 27: 325-331. (Pubitemid 29113542)
181. Renton MC, Snowden CP, (2005). Dopexamine and its role in the protection of hepatosplanchnic and renal perfusion in high-risk surgical and critically ill patients. Br J Anaesth 94: 459-467.
182. Reynolds JC, Rittenberger JC, Menegazzi JJ, (2007). Drug administration in animal studies of cardiac arrest does not reflect human clinical experience. Resuscitation 74: 13-26. (Pubitemid 46891663)
183. Richard C, Warszawski J, Anguel N, Deye N, Combes A, Barnoud D, et al,. (2003). Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: a randomized controlled trial. JAMA 290: 2713-2720. (Pubitemid 37475600)
184. Riekenberg S, Farhat K, Debarry J, Heine H, Jung G, Wiesmuller KH, et al,. (2009). Regulators of G-protein signalling are modulated by bacterial lipopeptides and lipopolysaccharide. FEBS J 276: 649-659.
185. Riepl B, Grassel S, Wiest R, Fleck M, Straub RH, (2010). Tumor necrosis factor and norepinephrine lower the levels of human neutrophil peptides 1-3 secretion by mixed synovial tissue cultures in osteoarthritis and rheumatoid arthritis. Arthritis Res Ther 12: R110.
186. Risoe PK, Wang Y, Stuestol JF, Aasen AO, Wang JE, Dahle MK, (2007). Lipopolysaccharide attenuates mRNA levels of several adenylyl cyclase isoforms in vivo. Biochim Biophys Acta 1772: 32-39. (Pubitemid 44960724)
187. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al,. (2001). Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: 1368-1377.
188. Rogausch H, del Rey A, Oertel J, Besedovsky HO, (1999). Norepinephrine stimulates lymphoid cell mobilization from the perfused rat spleen via beta-adrenergic receptors. Am J Physiol 276: R724-R730. (Pubitemid 29157501)
189. Rona G, (1985). Catecholamine cardiotoxicity. J Mol Cell Cardiol 17: 291-306. (Pubitemid 15030720)
190. Rondaij MG, Bierings R, Kragt A, Van Mourik JA, Voorberg J, (2006). Dynamics and plasticity of Weibel-Palade bodies in endothelial cells. Arterioscler Thromb Vasc Biol 26: 1002-1007. (Pubitemid 43732104)
191. Roshon MJ, Kline JA, Thornton LR, Watts JA, (2003). Cardiac UCP2 expression and myocardial oxidative metabolism during acute septic shock in the rat. Shock 19: 570-576.
192. Royse CF, Royse AG, Rohrlach R, Wright CE, Angus JA, (2007). The cardiovascular effects of adrenaline, dobutamine and milrinone in rabbits using pressure-volume loops and guinea pig isolated atrial tissue. Anaesth Intensive Care 35: 180-188. (Pubitemid 46647292)
193. Rudis MI, Basha MA, Zarowitz BJ, (1996). Is it time to reposition vasopressors and inotropes in sepsis? Crit Care Med 24: 525-537. (Pubitemid 26097849)
194. Ruffolo RR Jr, (1987). The pharmacology of dobutamine. Am J Med Sci 294: 244-248.
195. Russell JA, Walley KR, (2010). Vasopressin and its immune effects in septic shock. J Innate Immun 2: 446-460.
196. Russell JA, Walley KR, Singer J, Gordon AC, Hebert PC, Cooper DJ, et al,. (2008). Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358: 877-887. (Pubitemid 351397087)
197. Sandham JD, Hull RD, Brant RF, Knox L, Pineo GF, Doig CJ, et al,. (2003). A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 348: 5-14. (Pubitemid 36026341)
198. Sasada M, Smith S, (2003). Drugs in Anaesthesia & Intensive Care. Oxford University Press: Oxford.
199. Sato S, Ohnishi K, Sugita S, Okuda K, (1987). Splenic artery and superior mesenteric artery blood flow: nonsurgical Doppler US measurement in healthy subjects and patients with chronic liver disease. Radiology 164: 347-352. (Pubitemid 17097945)
200. Schilling T, Grundling M, Strang CM, Moritz KU, Siegmund W, Hachenberg T, (2004). Effects of dopexamine, dobutamine or dopamine on prolactin and thyreotropin serum concentrations in high-risk surgical patients. Intensive Care Med 30: 1127-1133. (Pubitemid 38833366)
201. Schmidt W, Hacker A, Gebhard MM, Martin E, Schmidt H, (1998). Dopexamine attenuates endotoxin-induced microcirculatory changes in rat mesentery: role of beta2 adrenoceptors. Crit Care Med 26: 1639-1645. (Pubitemid 28467670)
202. Schmoelz M, Schelling G, Dunker M, Irlbeck M, (2006). Comparison of systemic and renal effects of dopexamine and dopamine in norepinephrine-treated septic shock. J Cardiothorac Vasc Anesth 20: 173-178.
203. Silvestri M, Oddera S, Lantero S, Rossi GA, (1999). beta 2-agonist-induced inhibition of neutrophil chemotaxis is not associated with modification of LFA-1 and Mac-1 expression or with impairment of polymorphonuclear leukocyte antibacterial activity. Respir Med 93: 416-423. (Pubitemid 29265353)
204. Simon F, Giudici R, Scheuerle A, Groger M, Asfar P, Vogt JA, et al,. (2009). Comparison of cardiac, hepatic, and renal effects of arginine vasopressin and noradrenaline during porcine fecal peritonitis: a randomized controlled trial. Crit Care 13: R113.
205. Smythies J, Galzigna L, (1998). The oxidative metabolism of catecholamines in the brain: a review. Biochim Biophys Acta 1380: 159-162. (Pubitemid 28177547)
206. Spanos A, Jhanji S, Vivian-Smith A, Harris T, Pearse RM, (2010). Early microvascular changes in sepsis and severe sepsis. Shock 33: 387-391.
207. Van Der Spoel JI, Schultz MJ, Van Der Voort PH, de Jonge E, (2006). Influence of severity of illness, medication and selective decontamination on defecation. Intensive Care Med 32: 875-880. (Pubitemid 43781369)
208. Stiell IG, Hebert PC, Wells GA, Vandemheen KL, Tang AS, Higginson LA, et al,. (2001). Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet 358: 105-109. (Pubitemid 32709848)
209. Stone GW, McCullough PA, Tumlin JA, Lepor NE, Madyoon H, Murray P, et al,. (2003). Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA 290: 2284-2291. (Pubitemid 37430561)
210. Summers RJ, McMartin LR, (1993). Adrenoceptors and their second messenger systems. J Neurochem 60: 10-23. (Pubitemid 23006697)
211. Szabo C, Hasko G, Zingarelli B, Nemeth ZH, Salzman AL, Kvetan V, et al,. (1997). Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia. Immunology 90: 95-100. (Pubitemid 27008395)
212. Takakura K, Taniguchi T, Muramatsu I, Takeuchi K, Fukuda S, (2002). Modification of alpha1-adrenoceptors by peroxynitrite as a possible mechanism of systemic hypotension in sepsis. Crit Care Med 30: 894-899. (Pubitemid 34297814)
213. Takakura K, Xiaohong W, Takeuchi K, Yasuda Y, Fukuda S, (2003). Deactivation of norepinephrine by peroxynitrite as a new pathogenesis in the hypotension of septic shock. Anesthesiology 98: 928-934. (Pubitemid 36373228)
214. Tang C, Yang J, Wu LL, Dong LW, Liu MS, (1998). Phosphorylation of beta-adrenergic receptor leads to its redistribution in rat heart during sepsis. Am J Physiol 274: R1078-R1086. (Pubitemid 28217761)
215. Tavares M, Rezlan E, Vostroknoutova I, Khouadja H, Mebazaa A, (2008). New pharmacologic therapies for acute heart failure. Crit Care Med 36: S112-S120.
216. Toller WG, Stranz C, (2006). Levosimendan, a new inotropic and vasodilator agent. Anesthesiology 104: 556-569.
217. Trabold B, Gruber M, Frohlich D, (2007). Synthetic inotropes inhibit the expression of adhesion molecules and augment the expression of L-selectin in polymorphonuclear neutrophils. Resuscitation 74: 352-356. (Pubitemid 47021319)
218. Trager K, Radermacher P, Debacker D, Vogt J, Jakob S, Ensinger H, (2001). Metabolic effects of vasoactive agents. Curr Opin Anaesthesiol 14: 157-163. (Pubitemid 32240990)
219. Tumlin JA, Finkel KW, Murray PT, Samuels J, Cotsonis G, Shaw AD, (2005). Fenoldopam mesylate in early acute tubular necrosis: a randomized, double-blind, placebo-controlled clinical trial. Am J Kidney Dis 46: 26-34. (Pubitemid 40848430)
220. Turner JD, Gaspers LD, Wang G, Thomas AP, (2011). Uncoupling protein-2 modulates myocardial excitation-contraction coupling. Circ Res 106: 730-738.
221. Ueno S, Tanabe G, Yamada H, Kusano C, Yoshidome S, Nuruki K, et al,. (1998). Response of patients with cirrhosis who have undergone partial hepatectomy to treatment aimed at achieving supranormal oxygen delivery and consumption. Surgery 123: 278-286. (Pubitemid 28120366)
222. den Uil CA, Klijn E, Lagrand WK, Brugts JJ, Ince C, Spronk PE, et al,. (2008). The microcirculation in health and critical disease. Prog Cardiovasc Dis 51: 161-170.
223. Valentine RJ, Duke ML, Inman MH, Grayburn PA, Hagino RT, Kakish HB, et al,. (1998). Effectiveness of pulmonary artery catheters in aortic surgery: a randomized trial. J Vasc Surg 27: 203-211. discussion 211-2.
224. Van den Berghe G, de Zegher F, (1996). Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med 24: 1580-1590. (Pubitemid 26313763)
225. Wakita Y, (2007). Inotropic, chronotropic, and arrhythmogenic effects of dopamine on the isolated working heart of rabbit. J Physiol Sci 57: 147-157. (Pubitemid 46983413)
226. Wang N, Zhao DH, Sheng BH, (1991). Positive inotropic effect of apomorphine on guinea pig myocardium is mediated by dopamine DA1 receptors. Zhongguo Yao Li Xue Bao 12: 207-211.
227. Waschke J, Drenckhahn D, Adamson RH, Barth H, Curry FE, (2004). cAMP protects endothelial barrier functions by preventing Rac-1 inhibition. Am J Physiol Heart Circ Physiol 287: H2427-H2433. (Pubitemid 39557111)
228. Weiss M, Schneider EM, Tarnow J, Mettler S, Krone M, Teschemacher A, et al,. (1996). Is inhibition of oxygen radical production of neutrophils by sympathomimetics mediated via beta-2 adrenoceptors? J Pharmacol Exp Ther 278: 1105-1113. (Pubitemid 27166959)
229. Wenzel V, Krismer AC, Arntz HR, Sitter H, Stadlbauer KH, Lindner KH, (2004). A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med 350: 105-113. (Pubitemid 38056221)
230. Westphal M, Freise H, Kehrel BE, Bone HG, Van Aken H, Sielenkamper AW, (2004). Arginine vasopressin compromises gut mucosal microcirculation in septic rats. Crit Care Med 32: 194-200. (Pubitemid 38125581)
231. Wilson J, Woods I, Fawcett J, Whall R, Dibb W, Morris C, et al,. (1999). Reducing the risk of major elective surgery: randomised controlled trial of preoperative optimisation of oxygen delivery. BMJ 318: 1099-1103. (Pubitemid 29192147)
232. Woodhouse SP, Cox S, Boyd P, Case C, Weber M, (1995). High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation 30: 243-249. (Pubitemid 26016001)
233. Wright CD, Chen Q, Baye NL, Huang Y, Healy CL, Kasinathan S, et al,. (2008). Nuclear alpha1-adrenergic receptors signal activated ERK localization to caveolae in adult cardiac myocytes. Circ Res 103: 992-1000.
234. Wu LL, Dong LW, Liu MS, (1999). Alterations of G-protein and adenylate cyclase signaling in rat liver during the progression of sepsis. Shock 11: 39-43.
235. Wu LL, Yang SL, Yang RC, Hsu HK, Hsu C, Dong LW, et al,. (2003). G protein and adenylate cyclase complex-mediated signal transduction in the rat heart during sepsis. Shock 19: 533-537.
236. Xiao RP, Zhang SJ, Chakir K, Avdonin P, Zhu W, Bond RA, et al,. (2003). Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)-but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts. Circulation 108: 1633-1639. (Pubitemid 37187792)
237. Yaguchi A, Lobo FL, Vincent JL, Pradier O, (2004). Platelet function in sepsis. J Thromb Haemost 2: 2096-2102. (Pubitemid 40185767)
238. Yakaitis RW, Otto CW, Blitt CD, (1979). Relative importance of alpha and beta adrenergic receptors during resuscitation. Crit Care Med 7: 293-296.
239. Yamboliev IA, Mutafova-Yambolieva VN, (2005). PI3K and PKC contribute to membrane depolarization mediated by alpha2-adrenoceptors in the canine isolated mesenteric vein. BMC Physiol 5: 9.
240. Yates JC, Beamish RE, Dhalla NS, (1981). Ventricular dysfunction and necrosis produced by adrenochrome metabolite of epinephrine: relation to pathogenesis of catecholamine cardiomyopathy. Am Heart J 102: 210-221. (Pubitemid 11053151)
241. Youdim MBH, Fiberg JPM, Tipton KF, (1988). Monoamine oxidase. In:, Trendelenburg U, (ed.). Catecholamines. Springer-Verlag: Berlin, pp. 119-192.
242. Yu SK, Latour JG, (1977). Potentiation by alpha and inhibition by beta-adrenergic stimulations of rat platelet aggregation. A comparative study with human and rabbit platelets. Thromb Haemost 37: 413-422. (Pubitemid 8151188)
243. Zausig YA, Stowe DF, Zink W, Grube C, Martin E, Graf BM, (2006). A comparison of three phosphodiesterase type III inhibitors on mechanical and metabolic function in guinea pig isolated hearts. Anesth Analg 102: 1646-1652. (Pubitemid 43799830)
244. Zeng C, Zhang M, Asico LD, Eisner GM, Jose PA, (2007). The dopaminergic system in hypertension. Clin Sci (Lond) 112: 583-597. (Pubitemid 46849549)
245. Zhu XH, Zellweger R, Wichmann MW, Ayala A, Chaudry IH, (1997). Effects of prolactin and metoclopramide on macrophage cytokine gene expression in late sepsis. Cytokine 9: 437-446. (Pubitemid 27249977)
246. Ziegler DW, Wright JG, Choban PS, Flancbaum L, (1997). A prospective randomized trial of preoperative 'optimization' of cardiac function in patients undergoing elective peripheral vascular surgery. Surgery 122: 584-592. (Pubitemid 27407080)